Search Header Logo
'Another Good Year' Ahead for AstraZeneca: CEO Pascal Soriot

'Another Good Year' Ahead for AstraZeneca: CEO Pascal Soriot

Assessment

Interactive Video

Business, Health Sciences, Life Skills, Biology

University

Hard

Created by

Wayground Content

FREE Resource

The transcript covers the financial outlook for 2023, highlighting expected growth despite economic challenges. It discusses the potential impact of a new lung cancer drug and the success of a breast cancer treatment. The challenges and opportunities in the Chinese pharmaceutical market are explored, along with a comparison of R&D environments in Europe and the US. Finally, the CEO discusses succession planning and the company's strategic direction.

Read more

3 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What challenges has the pharmaceutical industry faced in China due to COVID?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What does the speaker believe is necessary for creating a successful life sciences sector?

Evaluate responses using AI:

OFF

3.

OPEN ENDED QUESTION

3 mins • 1 pt

What are the key components of the succession plan mentioned by the speaker?

Evaluate responses using AI:

OFF

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?